PATOU GARY — SEC Form 4 filings
SEC reporting owner CIK 1283535. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-08.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-06-05 to 2026-06-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 6,213 shares, $271,198 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 2,851 shares @ $41.11 ($117,205) in Xenon Pharmaceuticals Inc., filed 2024-11-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Director | 5 | — | 3 legs · 6,213 sh · $271,198 | 13 |
Form 4 filings — PATOU GARY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-08 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Sale (S): 1,322 @ $53.14 | EDGAR |
| 2026-06-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 2,645 · Option exercise (M): 2,645 (derivative) @ $0 · Grant/award (A): 10,507 (derivative) @ $0 · Grant/award (A): 1,593 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 17,012 (derivative) @ $0 · Grant/award (A): 2,645 (derivative) @ $0 | EDGAR |
| 2024-11-22 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 3,500 @ $7.38 · Tax withholding (F): 649 @ $39.80 · Sale (S): 2,851 @ $41.11 · Option exercise (M): 3,086 @ $13.48 · Tax withholding (F): 1,046 @ $39.80 · Sale (S): 2,040 @ $41.05 · +2 more | EDGAR |
| 2024-06-05 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 15,542 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1283535 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →